This year in the United States, almost 180,000 men will
be told that they have prostate cancer. After a diagnosis
of prostate cancer, a man and his family face several
choices regarding treatment. Decisions involve many factors,
personal as well as medical. Before making these decisions,
it is very important to learn about all the options available.
With this knowledge, a newly diagnosed prostate cancer
patient can participate more confidently with his doctor
in planning his individual treatment.
By age 50, about one-third of American men have microscopic
signs of prostate cancer. By age 75, half to three-quarters
of men will have some cancerous changes in their prostate
glands. Most of these cancers remain latent, producing
no signs of symptoms, or are so indolent, or slow-growing,
that they never become a serious threat to health.
A much smaller number of men will actually be treated
for prostate cancer. About 16 percent of American men
will be diagnosed with prostate cancer during their lives;
8 percent will develop significant symptoms; and 3 percent
will die of the disease.
ABOUT
THE PROSTATE
The prostate gland, a key part of the male reproductive
system, is linked closely with the urinary system. It is
a small gland that secretes much of the liquid portion of
semen, the milky fluid that transports sperm through the
penis during ejaculation.
The prostate is located just beneath the bladder, where
urine is stored, and in front of the rectum. It encircles,
like a donut, a section of the urethra. The urethra is the
tube that carries urine from the bladder out through the
penis. During ejaculation, semen is secreted by the prostate
through small pores of the urethra's walls.
The prostate is made up of three lobes encased in an outer
covering, or capsule. It is flanked on either side by the
seminal vesicles, a pair of pouch-like glands that contribute
secretions to the semen. Next to the seminal vesicles run
the two vas deferens, tubes that carry sperm from the testicles.
The testicles, in addition to manufacturing sperm, produce
testosterone, a male sex hormone that controls the prostate's
growth and function.
BACK
TO TOP
ABOUT
PROSTATE CANCER
Prostate cancer is a disease in which malignant (cancer)
cells form in the tissues of the prostate. The prostate
is a gland in the male reproductive system located just
below the bladder and in front of the rectum. It is about
the size of a walnut and surrounds the urethra (the tube
that empties urine from the bladder). The prostate gland
produces fluid that makes up part of the semen.
Prostate cancer is the most common non-skin malignancy
in men and is responsible for more deaths than any other
cancer, except for lung cancer. However, microscopic cancer
is found at autopsy in many if not most men. Approximately
16% of American men will be diagnosed with prostate cancer
sometime in their life.
Treatment options and prognosis depend on the stage of
the cancer, the Gleason score, and the patient’s age
and general health. With greater public awareness, early
detection is on the rise and mortality rates are declining.
Additionally, new advances in medical technology are enabling
cancer patients to go on to live active and productive lives
after their treatment.
BACK
TO TOP
CAUSES
OF PROSTATE CANCER
Prostate cancer is rare in men under 50 years old. However,
the risk increases steadily with age. By the time they are
80, more than half of all men will have some cancerous growth,
though in most cases it goes unnoticed. Prostate cancer
is usually slow-growing and, in men who have it, is often
not the cause of death.
The causes of prostate cancer are largely unknown. It is
clear that the chances of developing prostate cancer increase
in men over 50. Close relatives of men who have had prostate
cancer are also more likely to be affected. Ethnic origin
appears to play a part: men of African heritage seem to
be at highest risk, and men of Far Eastern descent the lowest.
It may be possible to reduce the risk by avoiding a high
fat diet through, for example, cutting down on dairy foods
and red meat.
Genetic Causes of Prostate Cancer
Prostate cancer seems to run in some families, suggesting
an inherited or genetic factor. Having a father or brother
with prostate cancer doubles a man's risk of developing
this disease. The risk is even higher for men with several
affected relatives, particularly if their relatives were
young at the time of diagnosis. Scientists have identified
several inherited genes that seem to increase prostate cancer
risk, but they probably account for only a small fraction
of cases. Genetic testing for these genes is not yet available.
Some inherited genes increase risk for more than one type
of cancer. For example, inherited mutations of the BRCA1
or BRCA2 genes are the reason that breast and ovarian cancers
are much more common in some families. The presence of these
gene mutations also increases prostate cancer risk. But
they are responsible for a very small percentage of prostate
cancer cases.
Possible Environmental Causes of Prostate Cancer
The most consistent risk factors associated with prostate
cancer are age, family history and African-American ethnicity.
Hormonal factors, as well as high levels of animal fat and
red meat in the diet, are also suspected risk factors.
Several occupational studies have linked farming to prostate
cancer risk. However, the variety of environmental exposures
in the farming community such as pesticides, engine exhausts,
solvents, dusts, animal viruses, fertilizers, fuels, and
specific microbes, have made it difficult for researchers
in previous studies to sort out which of these factors is
linked to specific diseases.
Exposure to certain agricultural pesticides may be associated
with an increased risk of prostate cancer among pesticide
applicators, according to a large recent study known as
the AHS (Agricultural Health Study) looking at the causes
of cancer and other diseases in the farming community.The
AHS is a collaborative effort involving the National Cancer
Institute (NCI), the National Institute of Environmental
Health Sciences, and the Environmental Protection Agency.
There is also a weak association between prostate cancer
and cadmium exposure, associated with the occupational environments
of mining and newspaper printing.
Possible Links to Vasectomy
Some studies have raised questions about a possible relationship
between vasectomy (an operation to cut or tie off the two
tubes that carry sperm out of the testicles) and the risk
of developing cancer, particularly prostate and testicular
cancer. Such a relationship, if proven, would be of importance,
as about one in six men over the age of 35 in the United
States has had a vasectomy.
BACK
TO TOP
SCREENING
& TESTING
This year in the United States, almost 180,000 men will
be told that they have prostate cancer. After a diagnosis
of prostate cancer, a man and his family face several choices
regarding treatment. Decisions involve many factors, personal
as well as medical. Before making these decisions, it is
very important that he learns about all the options available.
With this knowledge, a newly diagnosed prostate cancer patient
can participate more confidently with his doctor in planning
his individual treatment.
BACK
TO TOP
PREVENTION
Prostate cancer can sometimes be associated with known
risk factors for the disease. Many risk factors are modifiable
though not all can be avoided. Among those factors that
appear to aid in prevention are hormone medications, diet
adjustment and chemoprevention.
Hormonal Prevention
Studies are underway to discover the role of certain drugs,
such as finasteride, that reduce the amount of male hormone
as preventive agents for prostate cancer.
Diet and Lifestyle
A diet high in fat, especially animal fat, may be associated
with an increased risk of prostate cancer. Increased dietary
intake of fruits and vegetables has been associated with
a reduced risk of prostate cancer in some studies.
Chemoprevention
Chemoprevention is the use of specific natural or man-made
drugs, vitamins, or other agents to reverse, suppress, or
prevent cancer growth. Several agents, including difluoromethylornithine
(DFMO), isoflavonoids, selenium, vitamins D and E, and lycopene
have shown potential benefit in studies. Further studies
are needed to confirm this.